HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Banati, R. B. Articles by Duncan, J. S. Search for Related Content PubMed PubMed Citation Articles by Banati, R. B. Articles by Duncan, J. S.

[¹¹C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen’s encephalitis

From the MRC Cyclotron Unit (Drs. Banati, Goerres, Myers, Gunn, Turkheimer, and Jones, and D.J. Brooks), Imperial College School of Medicine, Hammersmith Hospital; the Epilepsy Group (Dr. Duncan), Institute of Neurology, National Hospital for Neurology and Neurosurgery, London, UK; and Max-Planck-Institute of Neurobiology (Dr. Kreutzberg), Munich, Germany.

Address correspondence and reprint requests to Dr. Richard Banati, MRC Cyclotron Unit, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK.

This study was designed to explore the feasibility of PET using [¹¹C](R)-PK11195 as an in vivo marker of activated microglia/brain macrophages for the assessment of neuroinflammation in Rasmussen’s encephalitis (RE). [¹¹C](R)-PK11195 PET was carried out in four normal subjects, two patients with histologically confirmed RE, and three patients with clinically stable hippocampal sclerosis and low seizure frequency. Binding potential maps showing specific binding of [¹¹C](R)-PK11195 were generated for each subject. Regional binding potential values were calculated for anatomically defined regions of interest after coregistration to and spatial transformation into the subjects’ own MRI. In one patient with RE who underwent hemispherectomy, the resected, paraffin-embedded brain tissue was stained with an antibody (CR3/43) that labels activated human microglia. Whereas specific binding of [¹¹C](R)-PK11195 in clinically stable hippocampal sclerosis was similar to that in normal brain, patients with RE showed a focal and diffuse increase in binding throughout the affected hemisphere. In RE, [¹¹C](R)-PK11195 PET can reveal in vivo the characteristic, unilateral pattern known from postmortem neuropathologic study. PET imaging of activated microglia/brain macrophages offers a tool for investigation of a range of brain diseases where neuroinflammation is a component and in which conventional MRI does not unequivocally indicate an inflammatory tissue reaction. [¹¹C](R)-PK11195 PET may help in the choice of appropriate biopsy sites and, further, may allow assessment of the efficacy of antiinflammatory disease–modifying treatment.

Key words: Peripheral benzodiazepine receptor—Mitochondrial benzodiazepine receptor—Mesial temporal sclerosis—Epilepsy.

This article has been cited by other articles:

				J Versijpt, J C Debruyne, K J Van Laere, F De Vos, J Keppens, K Strijckmans, E Achten, G Slegers, R A Dierckx, J Korf, et al. Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study Multiple Sclerosis, April 1, 2005; 11(2): 127 - 134. [Abstract] [PDF]

				C. G. Bien, T. Granata, C. Antozzi, J. H. Cross, O. Dulac, M. Kurthen, H. Lassmann, R. Mantegazza, J.-G. Villemure, R. Spreafico, et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: A European consensus statement Brain, March 1, 2005; 128(3): 454 - 471. [Abstract] [Full Text] [PDF]

				M.-K. Chen, K. Baidoo, T. Verina, and T. R. Guilarte Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization Brain, June 1, 2004; 127(6): 1379 - 1392. [Abstract] [Full Text] [PDF]

				R. B Banati Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain Br. Med. Bull., March 1, 2003; 65(1): 121 - 131. [Abstract] [Full Text] [PDF]

				A. Cagnin, R. Myers, R. N. Gunn, A. D. Lawrence, T. Stevens, G. W. Kreutzberg, T. Jones, and R. B. Banati In vivo visualization of activated glia by[11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion Brain, October 1, 2001; 124(10): 2014 - 2027. [Abstract] [Full Text] [PDF]

				G. W. Goerres, T. Revesz, J. Duncan, and R. B. Banati Imaging Cerebral Vasculitis in Refractory Epilepsy Using [11C] (R)-PK11195 Positron Emission Tomography Am. J. Roentgenol., April 1, 2001; 176(4): 1016 - 1018. [Full Text] [PDF]

				R. B. Banati, J. Newcombe, R. N. Gunn, A. Cagnin, F. Turkheimer, F. Heppner, G. Price, F. Wegner, G. Giovannoni, D. H. Miller, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity Brain, November 1, 2000; 123(11): 2321 - 2337. [Abstract] [Full Text] [PDF]

				S. Pappata, M. Levasseur, R. N. Gunn, R. Myers, C. Crouzel, A. Syrota, T. Jones, G. W. Kreutzberg, and R. B. Banati Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK11195 Neurology, October 10, 2000; 55(7): 1052 - 1054. [Abstract] [Full Text] [PDF]